The Oncosearch | Oncotarget

Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer Correction

Gonzalo Sequeira, Silvia I Vanzulli, Paola Rojas, Caroline Lamb, Lucas Colombo, María May, Alfredo Molinolo, Claudia Lanari

Published Apr 1, 2026 · Vol. 17, No. 1 · pp. 137-138

COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms Review

Charlotte Kuperwasser, Wafik S. El-Deiry

Published Mar 30, 2026 · Vol. 17, No. 1 · pp. 1-29

Keywords: COVID, vaccine, cancer, infection, lymphoma, leukemia, sarcoma, carcinoma

Retraction: HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas Retraction

Michalis V. Karamouzis, Georgia Dalagiorgou, Urania Georgopoulou, Afroditi Nonni, Michalis Kontos, Athanasios G. Papavassiliou

Published Dec 18, 2025

Retraction: Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells Retraction

Giuliana Gatti, Valeria Lucini, Silvana Dugnani, Angela Calastretti, Gilberto Spadoni, Annalida Bedini, Silvia Rivara, Marco Mor, Gianfranco Canti, Francesco Scaglione, Annamaria Bevilacqua

Published Dec 5, 2025 · Vol. 16, No. 1 · pp. 874-874

Retraction: Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells Retraction

Yao-Min Chen, Yu Liu, Hai-Yan Wei, Ke-Zhen Lv, Pei-Fen Fu

Published Dec 2, 2025 · Vol. 16, No. 1 · pp. 860-861

Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota Review

Hoang Do, Esther Asiamah, Mayanijesu Olorife, Arathi Pillai, Sakshi Patel, Ponniah Selvakumar, Sidhartha D. Ray, Ashakumary Lakshmikuttyamma

Published Nov 6, 2025 · Vol. 16, No. 1 · pp. 818-833

Keywords: cancer, gut microbiota, bifidobacterium

Anti-DNA virus agent cidofovir - loaded green synthesized cerium oxide nanoparticles (Nanoceria): Nucleic acids (DNA and RNA) binding affinity and cytotoxicity effects Research Paper

Nahid Shahabadi, Saba Zendehcheshm, Fatemeh Khademi, Mohammad Mahdavi

Published Oct 23, 2025 · Vol. 16, No. 1 · pp. 768-789

Keywords: CeO₂ NPs, green synthesis, DNA interaction, RNA interaction, cytotoxicity

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields Research Paper

Hugo Jimenez, Denise Gibo, Sambad Sharma, Michael Pennison, Lance D. Miller, Minghui Wang, Kimberly Sheffield, Liyue Zhang, Allan Johansen, Preeya Achari, Callum Mcgrath, Sean Lester, Jason Tang, Kojo Agyemang, Annette Johnson, Christopher T. Whitlow, Michael Chan, Kounosuke Watabe, Ralph D’Agostino Jr., Janaka Liyanage, Asfar Azmi, Geoffrey Barger, Alexandre Barbault, Glenn J. Lesser, Waldemar Debinski, Boris C. Pasche

Published Oct 2, 2025 · Vol. 16, No. 1 · pp. 741-757

Keywords: amplitude-modulated radiofrequency electromagnetic fields, glioblastoma, TheraBionic, CACNA1H, Ca_v3.2

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

Valeriy Domenyuk, Kasey Benson, Peggy Carter, Daniel Magee, Jian Zhang, Nitin Bhardwaj, Hongseok Tae, James Wacker, Foram Rathi, Siobhan Miick, Aastha Kohli, Joshua Carroll, Lori Cuyugan, Evelyn Perez, Wayeesha Zhang, John Collins, Patrick Kennedy, Jeremy Ellis, Adam Stark, Andrey Loskutov, Brittany Cuttone, Blake Taylor, Rebecca Feldman, Jeff Swenson, David Bryant, Robert Hahn-Lowry, Raunaq Kaushal, Jennifer R. Ribeiro, Jim Abraham, Milan Radovich, George W. Sledge, Matthew Oberley, David Spetzler

Published Aug 6, 2025 · Vol. 16, No. 1 · pp. 642-659

Keywords: companion diagnostic, molecular profiling, solid tumors, precision oncology, next-generation sequencing

PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion Research Paper

Jassy Mary S. Lazarte, Kweku Ofosu-Asante, Syreeta L. Tilghman, Nazarius S. Lamango

Published Jul 22, 2025 · Vol. 16, No. 1 · pp. 621-641

Keywords: PCAIs, ROS, MAPK, PI3K/AKT, LTLT-Ca cells

Comprehensive genomic profiling of over 10,000 advanced solid tumors Research Paper

Jean-Paul De La O, Jess R. Hoag, Angela K. Deem, Min Wang, Arthur Starodynov, Sameer S. Udhane, Janine R. LoBello, Nishitha Therala, David W. Hall, Gargi D. Basu, Frederick L. Baehner

Published Jul 19, 2025 · Vol. 16, No. 1 · pp. 587-603

Keywords: solid tumors, comprehensive genomic profiling, matched therapy, gene fusions, limit of detection

Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms Review

Shreya Shyamsunder, Zhixin Lu, Vinita Takiar, Susan E. Waltz

Published Jun 16, 2025 · Vol. 16, No. 1 · pp. 508-530

Keywords: EGFR, RTKs, breast cancer, head and neck cancer, resistance mechanisms

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression Correction

María Laura Polo, Marina Riggio, María May, María Jimena Rodríguez, María Cecilia Perrone, Melody Stallings-Mann, Diego Kaen, Marlene Frost, Matthew Goetz, Judy Boughey, Claudia Lanari, Derek Radisky, Virginia Novaro

Published May 20, 2025 · Vol. 16, No. 1 · pp. 379-381

Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis Review

Rahaf Alchazal, Khaled J. Zaitoun, Mohammad Al-Qudah, Ghena Zaitoun, Amira M. Taha, Othman Saleh, Mohammad Alqudah, Mohammad Abuawwad, Mohammad Taha, Abdullah Yousef Aldalati

Published Apr 28, 2025 · Vol. 16, No. 1 · pp. 311-326

Keywords: breast cancer, cancer risk factors, blood group antigens, tumor

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients Precision Oncology

Wafik S. El-Deiry, Catherine Bresson, Fanny Wunder, Benedito A. Carneiro, Don S. Dizon, Jeremy L. Warner, Stephanie L. Graff, Christopher G. Azzoli, Eric T. Wong, Liang Cheng, Sendurai A. Mani, Howard P. Safran, Casey Williams, Tobias Meissner, Benjamin Solomon, Eitan Rubin, Angel Porgador, Guy Berchem, Pierre Saintigny, Amir Onn, Jair Bar, Raanan Berger, Manon Gantenbein, Zhen Chen, Cristiano de Pádua Souza, Rui Manuel Vieira Reis, Marina Sekacheva, Andrés Cervantes, William L. Dahut, Christina M. Annunziata, Kerri Gober, Khaled M. Musallam, Humaid O. Al-Shamsi, Ibrahim Abu-Gheida, Ramon Salazar, Sewanti Limaye, Adel T. Aref, Roger R. Reddel, Mohammed Ussama Al Homsi, Abdul Rouf, Said Dermime, Jassim Al Suwaidi, Catalin Vlad, Rares Buiga, Amal Al Omari, Hikmat Abdel-Razeq, Luis F. Oñate-Ocaña, Finn Cilius Nielsen, Leah Graham, Jens Rueter, Anthony M. Joshua, Eugenia Girda, Steven Libutti, Gregory Riedlinger, Mohammed E. Salem, Carol J. Farhangfar, Ruben A. Mesa, Bishoy M. Faltas, Olivier Elemento, C.S. Pramesh, Manju Sengar, Satoru Aoyama, Sadakatsu Ikeda, Ioana Berindan-Neagoe, Himabindu Gaddipati, Mandar Kulkarni, Elisabeth Auzias, Maria Gerogianni, Nicolas Wolikow, Simon Istolainen, Pessie Schlafrig, Naftali Z. Frankel, Amanda R. Ferraro, Jim Palma, Alejandro Piris Gimenez, Alberto Hernando-Calvo, Enriqueta Felip, Apostolia M. Tsimberidou, Roy S. Herbst, Josep Tabernero, Richard L. Schilsky, Jia Liu, Yves Lussier, Jacques Raynaud, Gerald Batist, Shai Magidi, Razelle Kurzrock

Published Mar 12, 2025 · Vol. 16, No. 1 · pp. 140-162

Keywords: precision oncology, N-of-1 basket trials, AI algorithms, digital pathology, drug access

Signaling pathway dysregulation in breast cancer Review

Dinara Ryspayeva, Attila A. Seyhan, William J. MacDonald, Connor Purcell, Tyler J. Roady, Maryam Ghandali, Nataliia Verovkina, Wafik S. El-Deiry, Martin S. Taylor, Stephanie L. Graff

Published Mar 7, 2025 · Vol. 16, No. 1 · pp. 168-201

Keywords: breast cancer, oncogenic pathways, signal dysregulation in cancer, therapeutic approaches, clinical trials

COMETgazing - interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE Editorial

Mangesh A. Thorat

Published Mar 3, 2025 · Vol. 16, No. 1 · pp. 138-139

Keywords: DCIS, invasive breast cancer, active monitoring, overdiagnosis, TILs

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Whitney L. Hensing, Emily L. Podany, James J. Sears, Shaili Tapiavala, Andrew A. Davis

Published Jan 9, 2025 · Vol. 16, No. 1 · pp. 11-27

Keywords: breast cancer, HER2-low, genomics

Initiation of tumor dormancy by the lymphovascular embolus Research Paper

Yin Ye, Justin Wang, Michael G. Izban, Billy R. Ballard, Sanford H. Barsky

Published Oct 2, 2024 · Vol. 15, No. 1 · pp. 726-740

Keywords: dormancy, lymphovascular embolus, mTOR, E-cadherin proteolysis

Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties Research Paper

Alan Halim, Nasreen Al-Qadi, Elizabeth Kenyon, Kayla N. Conner, Sujan Kumar Mondal, Zdravka Medarova, Anna Moore

Published Aug 17, 2024 · Vol. 15, No. 1 · pp. 591-606

Keywords: breast cancer, metastasis, stem-like cells, nanoparticle, miR-10b

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer Correction

COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms Review

Retraction: HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas Retraction

Retraction: Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells Retraction

Retraction: Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells Retraction

Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota Review

Anti-DNA virus agent cidofovir - loaded green synthesized cerium oxide nanoparticles (Nanoceria): Nucleic acids (DNA and RNA) binding affinity and cytotoxicity effects Research Paper

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields Research Paper

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion Research Paper

Comprehensive genomic profiling of over 10,000 advanced solid tumors Research Paper

Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms Review

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression Correction

Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis Review

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients Precision Oncology

Signaling pathway dysregulation in breast cancer Review

COMETgazing - interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE Editorial

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Initiation of tumor dormancy by the lymphovascular embolus Research Paper

Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer Correction

COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms Review

Retraction: HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas Retraction

Retraction: Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells Retraction

Retraction: Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells Retraction

Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota Review

Anti-DNA virus agent cidofovir - loaded green synthesized cerium oxide nanoparticles (Nanoceria): Nucleic acids (DNA and RNA) binding affinity and cytotoxicity effects Research Paper

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields Research Paper

Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion Research Paper

Comprehensive genomic profiling of over 10,000 advanced solid tumors Research Paper

Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms Review

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression Correction

Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis Review

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients Precision Oncology

Signaling pathway dysregulation in breast cancer Review

COMETgazing - interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE Editorial

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Initiation of tumor dormancy by the lymphovascular embolus Research Paper

Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties Research Paper

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper